RSS Feed Link

eMed Blog

Considering crowdfunding? Get an in-depth look at one new platform: Looking for early-stage financing for your life science or digital health startup? Crowdfunding, in which individuals and teams can raise money over the Internet from dozens or thousands of sources in small amounts, has become a popular financing tool.
[More]; Posted by: Christina Hernandez Sherwood; on May 16, 2013; Comments (0); Category: Kauffman Words of Wisdom
Funding insights for entrepreneurs from top med tech investors: At the MedTech Investing Conference in Minneapolis last week, two sessions focused specifically on med tech funding: from early- and late-stage investing to emerging funding sources available to private companies.
[More]; Posted by: Christina Hernandez Sherwood; on May 13, 2013; Comments (0); Category: Events
BioCurious: Bio-hacker space cofounder on funding and regulatory issues: BioCurious is a Silicon Valley bio-hacker space with a dual mission: community education and work with entrepreneurs. Cofounder Raymond McCauley, who is also chair of biotechnology at Singularity University, said BioCurious provides lab space, equipment and a community for entrepreneurs.
[More]; Posted by: Christina Hernandez Sherwood; on April 09, 2013; Comments (0); Category: Entrepreneurial Challenges
New eMed white paper: Funding Sources for Life Science Startups: eMed has published the first in a series of white papers focused on issues key to life science and digital health entrepreneurs. The first white paper, Funding Sources for Life Science Startups, offers countless ideas on how to raise capital for a healthcare product: from a drug or device to the emerging health IT and mobile health segments.
[More]; Posted by: Christina Hernandez Sherwood; on April 03, 2013; Comments (0); Category: eMed Research Papers
Morpheus Medical: Co-founder shares insights on securing funding and managing costs: With the goal of revolutionizing cardiac MRI, Morpheus Medical has developed software that takes the process from three hours to about 20 minutes. The company was launched about a year and a half ago when entrepreneurs who wanted to use computational processing to help with the diagnosis of disease came together with radiologists from Stanford University to commercialize the product.
[More]; Posted by: Christina Hernandez Sherwood; on March 12, 2013; Comments (0); Category: Entrepreneurial Challenges
DioGenix: CEO Offers Tips on Pursuing the Right Product and Investors: DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
[More]; Posted by: MedCityNews .com; on February 19, 2013; Comments (0); Category: Entrepreneurial Challenges